Executives
Evaluate capacity, reliability, cost, and strategic automation roadmaps.
Request access
Start a Bioseon access conversation.
Tell us about your facility, modality, and operational goals. Bioseon works with CDMOs and biopharma manufacturers exploring autonomous bioprocess control.
48h
Response target
We aim to review qualified manufacturing inquiries promptly and route them to a focused scoping conversation.
Share the process context that matters.
Use the form for production, MSAT, digital manufacturing, quality, executive, and partnership inquiries. Please avoid confidential process parameters until a formal agreement is in place.
- mAbs, vaccines, recombinant proteins, and cell and gene
- Fed-batch, perfusion, purification, and batch records
- Shadow deployments before closed-loop control
What happens next
A practical path from first conversation to measured manufacturing value.
- 01
Submit
Share the facility, modality, and operational area you want to evaluate.
- 02
Scoping call
Align on process context, data availability, constraints, and decision makers.
- 03
Shadow deployment
Run Bioseon in observation mode against live or historical signals.
- 04
Closed-loop
Advance into controlled recommendations or actions only after validation.
- 05
Expand
Extend across vessels, skids, modalities, or facilities as evidence accumulates.
Teams responsible for batch outcomes.
MSAT champions
Translate process understanding into soft sensors and control strategies.
Technical and QA
Assess data integrity, validation, Part 11, and operational fit.
Ways to engage
Request access
Start with a focused fit conversation and process area review.
Use formBook a scoping call
Discuss a candidate facility, data availability, and target use case.
Start scopingPartnerships
Explore collaboration across instruments, automation, MES, or services.
Contact usRegional conversations, no fabricated offices.
Bioseon is early-stage and independent. We discuss deployments by region and facility needs rather than publishing street addresses.
North America
Biopharma and CDMO manufacturing hubs across major markets.
Europe
GMP manufacturing networks, quality teams, and digital programs.
APAC
Growing biologics capacity with strong interest in automation and quality.
Support and security quick links
Security and validation
Review our approach to access, audit trails, and regulated environments.
Open securityResources
Read practical guides on PAT, soft sensing, GMP, and Part 11.
Open resourcesWhat to include for a productive first call.
A concise overview of modality, manufacturing stage, control goals, and data systems helps us prepare useful questions before we meet.
- Target modality and process mode
- Primary challenge, such as titer drift or review load
- Available PAT, historian, MES, or LIMS signals
- Validation and quality stakeholders
FAQ
Do we need to be ready for closed-loop control?
No. Many conversations start with observation mode, historical analysis, or a shadow deployment.
Can Bioseon work with existing historians and MES?
The platform is designed to connect with manufacturing data systems while preserving context, access controls, and auditability.
Which modalities are a fit?
Bioseon focuses on mAbs, vaccines, GLP-1 and recombinant proteins, and cell and gene workflows.
Should we send confidential batch data now?
No. Start with non-confidential context until agreements and security reviews are complete.
Why teams contact us
Autonomy in biologics manufacturing starts with trust: the signal must be grounded, the action must be explainable, and the record must survive quality review.
Ready to evaluate Bioseon?
Request access and we will help scope the right first use case for your manufacturing context.